M11.119 Familial chondrocalcinosis, unspecified shoulder

Name of the Condition

• Familial chondrocalcinosis, unspecified shoulder

Summary

Familial chondrocalcinosis, unspecified shoulder is a hereditary condition marked by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the shoulder joint and surrounding tissues. This leads to inflammation, pain, and potential joint damage. It is part of the broader group of crystal arthropathies and is distinguished by its familial inheritance pattern and shoulder-specific involvement. Diagnosis typically involves clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, unspecified shoulder is caused by genetic mutations that influence calcium pyrophosphate crystal formation in the shoulder’s cartilage, synovium, or periarticular structures. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Family history of chondrocalcinosis or related crystal arthropathies.
• Advanced age (increases likelihood of crystal deposition).
• Metabolic conditions affecting calcium or phosphate levels.
• Shoulder trauma or surgery (may trigger crystal release).
• Chronic inflammatory joint diseases.

Symptoms

• Shoulder pain, swelling, and stiffness.
• Recurrent episodes of acute inflammation (pseudogout).
• Limited range of motion in the shoulder.
• Joint tenderness or warmth.
• Possible joint deformity over time.

Diagnosis

Diagnosis involves a combination of clinical assessment, imaging studies (e.g., X-rays, ultrasound, or MRI to detect crystal deposits or joint changes), and sometimes analysis of joint fluid or tissue to identify CPPD crystals. Family history and genetic testing may also support the diagnosis, particularly in familial cases.

Treatment Options

• Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation.
• Colchicine for acute flare-ups.
• Corticosteroid injections to alleviate severe inflammation.
• Physical therapy to maintain joint function and mobility.
• Management of underlying metabolic conditions (if present).
• In severe cases, surgical intervention may be considered for joint damage.

Prognosis and Follow-Up

Prognosis varies depending on the extent of joint damage and response to treatment. Early diagnosis and management can help control symptoms and slow progression. Regular follow-up with a healthcare provider is recommended to monitor joint health, adjust treatment, and address complications.

Complications

• Chronic joint pain and stiffness.
• Progressive joint damage or osteoarthritis.
• Recurrent acute flare-ups.
• Reduced shoulder function or mobility.
• Potential disability if left untreated.

Lifestyle & Prevention

• Maintain a healthy weight to reduce joint stress.
• Avoid shoulder trauma or overuse.
• Manage metabolic conditions (e.g., calcium or phosphate imbalances).
• Engage in regular, low-impact exercise to support joint health.
• Follow prescribed treatment plans to prevent flare-ups.

When to Seek Professional Help

Seek medical attention if you experience persistent shoulder pain, swelling, or stiffness, especially with a family history of chondrocalcinosis. Acute, severe symptoms (e.g., sudden intense pain, inability to move the shoulder) require prompt evaluation.

Tips for Medical Coders

When coding for familial chondrocalcinosis, unspecified shoulder (M11.119), ensure documentation supports the hereditary nature of the condition and shoulder involvement. Verify that the diagnosis aligns with clinical findings, imaging, or crystal identification. Confirm the absence of specified laterality (e.g., right or left shoulder) to justify the "unspecified" designation.